Innovating Works

AXIOGENESIS AG

Desconocido
METACELL-TM: METAbolism analysis made easy for CELL Translational Medicine NCARDIA AG participó en un H2020: H2020-FTIPilot-2016 "The healthcare industry is experiencing unprecedented rates of drug failure, long development times and high costs - because current lab te...
2016-11-17 - 2019-04-30 | Financiado
DeCISIoN: Drug CandIdates ScreenINg NCARDIA AG participó en un H2020: H2020-SMEInst-2016-2017 Pluriomics is an international Dutch/Belgian biotech company specialised in developing stem cell-based assays for cardiac safety pharmacolog...
2016-06-03 - 2018-12-31 | Financiado
ELASTISLET: Tailored Elastin like Recombinamers as Advanced Systems for Cell Therapies in Diabetes Mellitus a S... NCARDIA AG participó en un H2020: H2020-NMP-2014-2015 ELASTISLET aims to create a breakthrough development in encapsulation technology and its use in cell and tissue therapies for the treatment...
2015-05-28 - 2019-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.